Once the quality of the new AlphaScreen assay to assess D2R/A2AR oligomers in human tissue was validated (i.e., Z’ factor and S/B), we aimed to gauge potential changes associated with PD pathophysiology. This evidence concerns the gene ADORA2A and Parkinson disease.